Related references
Note: Only part of the references are listed.Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells
Ivana Vrhovac Madunic et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
Stefania Gorini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
Maria Paula Ceballos et al.
TOXICOLOGY LETTERS (2018)
Bioactive flavonoids in medicinal plants: Structure, activity and biological fate
Tian-yang Wang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
P-gp modulating effect of Azadirachta indica extract in multidrug-resistant cancer cell lines
M. Kawami et al.
PHARMAZIE (2018)
Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
Masatoshi Kudo
ONCOLOGY (2017)
Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer
Mingtong Ye et al.
JOURNAL OF CANCER (2017)
Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide
Michael Koukourakis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect
Xi-sha Chen et al.
ACTA PHARMACOLOGICA SINICA (2016)
The Warburg effect: 80 years on
Michelle Potter et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
Alberto A. Gabizon et al.
DRUG RESISTANCE UPDATES (2016)
Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment
Giuseppina Di Stefano et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity
D. Agudelo et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2016)
Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin
M. Pacifico de Freitas Segredo et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
Chemistry and Biological Activities of Flavonoids: An Overview
Shashank Kumar et al.
SCIENTIFIC WORLD JOURNAL (2013)
Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair
Daniel Arango et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Treatment of Hepatocellular Carcinoma: A Systematic Review
Shibo Lin et al.
LIVER CANCER (2012)
Antioxidant and prooxidant properties of flavonoids
D. Prochazkova et al.
FITOTERAPIA (2011)
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
Ramon C. Sun et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Spectrophotometric analysis of flavonoid-DNA interactions and DNA damaging/protecting and cytotoxic potential of flavonoids in human peripheral blood lymphocytes
Gordana Rusak et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy
Roberto Scatena et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
An overview of DNA and RNA bindings to antioxidant flavonoids
C. D. Kanakis et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity
MR Webb et al.
BIOCHEMICAL JOURNAL (2004)
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
YH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component
L Zheng et al.
CELL (2003)
Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C)
HP Liu et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Share Paper
